Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Depreciation & Amortization (CF) (2024 - 2025)

Historic Depreciation & Amortization (CF) for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to $179000.0.

  • Connect Biopharma Holdings' Depreciation & Amortization (CF) rose 170.45% to $179000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $681000.0, marking a year-over-year increase of 3565.74%. This contributed to the annual value of $660000.0 for FY2024, which is 833.33% down from last year.
  • Connect Biopharma Holdings' Depreciation & Amortization (CF) amounted to $179000.0 in Q3 2025, which was up 170.45% from $171000.0 recorded in Q2 2025.
  • Connect Biopharma Holdings' 5-year Depreciation & Amortization (CF) high stood at $179000.0 for Q3 2025, and its period low was $158000.0 during Q4 2024.